The prevalence and relevance of substance use in detained schizophrenic patients

被引:44
|
作者
Wheatley, M [1 ]
机构
[1] Kneesworth House Hosp, Northampton NN1 5RX, England
来源
JOURNAL OF FORENSIC PSYCHIATRY | 1998年 / 9卷 / 01期
关键词
substance use; schizophrenia; co-morbidity; assessment of dangerousness;
D O I
10.1080/09585189808402182
中图分类号
DF [法律]; D9 [法律];
学科分类号
0301 ;
摘要
Prevalence of substance use and patterns of choice of specific substances were investigated in a sample of schizophrenic patients detained under the Mental Health Act 1983 and residing in conditions of medium security in the independent health care sector. Patient characteristics (age and legal status) differentiating substance-using patients from non-users mere explored as was the relevance of substance use to the assessment of dangerousness. The results confirm the high co-morbidity of substance use and schizophrenia with respect to detained and forensic patients. Cannabis and alcohol were most frequently used; indeed, a high proportion of patients presented a history of using only alcohol or cannabis, either in isolation or in combination. Stimulant use was prominent whereas opiate use was rare. The majority of substance-using patients were poly-substance users. Substance-using patients were younger and more frequently had a forensic history Substance use was found to be a significant issue in risk assessment.
引用
收藏
页码:114 / 129
页数:16
相关论文
共 50 条
  • [21] Prevalence of Alcohol and Other Substance Use in Patients with Eating Disorders
    Fouladi, Farnaz
    Mitchell, James E.
    Crosby, Ross D.
    Engel, Scott G.
    Crow, Scott
    Hill, Laura
    Le Grange, Daniel
    Powers, Pauline
    Steffen, Kristine J.
    EUROPEAN EATING DISORDERS REVIEW, 2015, 23 (06) : 531 - 536
  • [22] Prevalence of substance use disorder in Thai patients with bipolar disorders
    Arunpongpaisal, S.
    Maneeganondh, S.
    Jarassaeng, N.
    Pimpanit, V.
    Boontooch, K.
    BIPOLAR DISORDERS, 2014, 16 : 111 - 111
  • [23] The prevalence of the sleep disturbances among the patients with substance use disorders
    Vetrova, M. V.
    Kuchmenko, D. N.
    Genina, I. N.
    Goncharov, O., V
    Rybakova, K., V
    Semenova, N., V
    Zubova, E. Yu
    Kiselev, A. S.
    Neznanov, N. G.
    Krupitsky, E. M.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 26 - 35
  • [24] The prevalence of QT prolongation in a population of patients with substance use disorders
    Scott, Alexander J.
    Dunlop, Adrian J.
    Brown, Amanda
    Sadler, Craig
    Isbister, Geoffrey K.
    DRUG AND ALCOHOL REVIEW, 2017, 36 (02) : 239 - 244
  • [25] Prevalence of Substance Use in Patients With Cancer Receiving Radiation Therapy
    Choflet, Amanda
    Narang, Amol K.
    Hoofring, Laura Herald
    Bonerigo, Sarah
    Mian, Omar Y.
    Katulis, Lisa
    Cheng, Zhi
    Appling, Susan
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2016, 20 (04) : 397 - 402
  • [26] Changing patterns of illicit substance use among schizophrenic patients: 1984-1996
    Patkar, AA
    Alexander, RC
    Lundy, A
    Certa, KM
    AMERICAN JOURNAL ON ADDICTIONS, 1999, 8 (01): : 65 - 71
  • [27] POSITIVE AND NEGATIVE SYNDROME TYPOLOGY IN SCHIZOPHRENIC-PATIENTS WITH PSYCHOACTIVE SUBSTANCE USE DISORDERS
    ROSENTHAL, RN
    HELLERSTEIN, DJ
    MINER, CR
    COMPREHENSIVE PSYCHIATRY, 1994, 35 (02) : 91 - 98
  • [28] Comparative retrospective study of schizophrenic patients with/without substance use disorder and employment in Bulgaria
    Chumpalova, P.
    Valtchev, V.
    Tumbev, L.
    Stoimenova-Popova, M.
    Veleva, I.
    Stoychev, K.
    EUROPEAN PSYCHIATRY, 2019, 56 : S54 - S55
  • [29] Substance abuse (including nicotine) in schizophrenic patients
    McEvoy, JP
    Allen, TB
    CURRENT OPINION IN PSYCHIATRY, 2003, 16 (02) : 199 - 205
  • [30] SWEAT IN SCHIZOPHRENIC PATIENTS - INDENTIFICATION OF ODOROUS SUBSTANCE
    SMITH, K
    THOMPSON, GF
    KOSTER, HD
    SCIENCE, 1969, 166 (3903) : 398 - &